Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1Phase 3 1

Status

Recruiting 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 20CNS 11Head & Neck 10Sarcoma 7Thoracic 6Breast 5Genitourinary 3Dermatologic 3Tumor-Agnostic 2Gynecologic 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 2Pathologic Complete Response 1

Interventions

Carboplatin 194pembrolizumab 157Pemetrexed 138Cisplatin 119durvalumab 76Paclitaxel 76osimertinib 69Nivolumab 68Specimen Handling 65Docetaxel 64Magnetic Resonance Spectroscopy 54atezolizumab 52Etoposide 47Gemcitabine 46Radiotherapy 44Radiosurgery 42Drug Therapy 33130-nm albumin-bound paclitaxel 33Ipilimumab 28Bevacizumab 27Taxes 24cemiplimab 23Cetuximab 23tislelizumab 21Platinum 21Immunoglobulin G 20Biopsy 20amivantamab 19Radiation 19Disulfides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Surgical Procedures, Operative × Thoracic × 90 days × Clear all
NCT06632327 2026-05-08

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
1,100 enrolled
Thoracic

Lung Neoplasms

NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT05882513 2026-04-24

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Active not recruiting
36 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06114108 2026-04-02

salVage

Swiss Cancer Institute

Phase NA Recruiting
128 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06083454 2026-03-13

Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)

University of Iowa

Phase 1 Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡